ESSEX INVESTMENT MANAGEMENT CO LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 220 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 4.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
ESSEX INVESTMENT MANAGEMENT CO LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$10,788,000
+77.7%
807,424
+86.4%
0.85%
+18.6%
Q3 2018$6,072,000
-10.9%
433,131
-0.0%
0.71%
-16.3%
Q2 2018$6,812,000
-4.7%
433,337
-0.3%
0.85%
-9.3%
Q1 2018$7,150,000
-11.8%
434,624
-3.1%
0.94%
-12.1%
Q4 2017$8,104,000
+38.1%
448,712
+47.6%
1.07%
+34.0%
Q3 2017$5,869,000
+31.3%
304,101
-19.7%
0.80%
+24.7%
Q2 2017$4,470,000
+23.9%
378,846
+15.0%
0.64%
+13.1%
Q1 2017$3,609,000
+114.1%
329,305
+41.8%
0.57%
+103.6%
Q4 2016$1,686,000
+50.4%
232,267
+34.7%
0.28%
+53.6%
Q3 2016$1,121,000172,3890.18%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders